DDD Partners LLC grew its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 7,732.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 92,270 shares of the conglomerate’s stock after buying an additional 91,092 shares during the quarter. Danaher comprises 1.2% of DDD Partners LLC’s investment portfolio, making the stock its 27th biggest holding. DDD Partners LLC’s holdings in Danaher were worth $18,293,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. WFA of San Diego LLC purchased a new stake in shares of Danaher during the 2nd quarter worth $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher in the second quarter valued at about $27,000. TruNorth Capital Management LLC purchased a new stake in Danaher during the third quarter worth about $28,000. Tripletail Wealth Management LLC acquired a new position in Danaher during the third quarter worth about $31,000. Finally, Heartwood Wealth Advisors LLC purchased a new position in Danaher in the third quarter valued at about $37,000. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insiders Place Their Bets
In other Danaher news, Director Teri List sold 3,298 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the sale, the director directly owned 20,762 shares in the company, valued at $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Read Our Latest Stock Report on DHR
Danaher Stock Down 1.2%
Shares of NYSE DHR opened at $212.37 on Friday. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $150.01 billion, a PE ratio of 42.14, a P/E/G ratio of 2.90 and a beta of 0.91. The firm has a fifty day moving average of $228.63 and a 200-day moving average of $215.46. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last issued its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The firm had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm earned $2.14 earnings per share. On average, analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.
Danaher Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were issued a $0.32 dividend. The ex-dividend date was Friday, December 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 25.40%.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- ALERT: Drop these 5 stocks before January 2026!
- Buy This Stock Now
- Trump & Musk’s Secret Bet on Silver — Exposed
- Silicon Valley insiders hint at 12-month AI warning
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
